Joseph Fourier University

AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program

Retrieved on: 
Monday, October 17, 2022

AcuraBio brings two decades of experience in innovative therapeutics for customers in the biotech, pharmaceutical, and animal health industries.

Key Points: 
  • AcuraBio brings two decades of experience in innovative therapeutics for customers in the biotech, pharmaceutical, and animal health industries.
  • The CDMO provides recombinant proteins, vaccines, and complex live biotherapeutic products to customers on the leading edge in emerging therapeutics.
  • Dr. Haifer stated "These senior executive appointments are key to shaping the company as we move forward with our growth plans.
  • AcuraBio will immediately benefit from Guillaume Herry's experience with companies in the US, Europe and Australia designing and implementing growth strategies.

AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program

Retrieved on: 
Thursday, October 20, 2022

AcuraBio brings two decades of experience in innovative therapeutics for customers in the biotech, pharmaceutical, and animal health industries.

Key Points: 
  • AcuraBio brings two decades of experience in innovative therapeutics for customers in the biotech, pharmaceutical, and animal health industries.
  • The CDMO provides recombinant proteins, vaccines, and complex live biotherapeutic products to customers on the leading edge in emerging therapeutics.
  • "AcuraBio will immediately benefit from Guillaume Herry's experience with companies in the US, Europe and Australia designing and implementing growth strategies."
  • Mr. Herry said: "I'm excited to be part of this new phase of growth and to be working with Glenn and the Ampersand team.

Nobul Expands Leadership Team With Four New Key Executives to Accelerate Growth

Retrieved on: 
Friday, November 12, 2021

"I am very pleased to have these highly accomplished executives from Silicon Valley join Nobul's leadership team to fuel our growth.

Key Points: 
  • "I am very pleased to have these highly accomplished executives from Silicon Valley join Nobul's leadership team to fuel our growth.
  • They each have proven track records of successfully scaling businesses much smaller than Nobul to multibillion-dollar market caps and attracting stellar talent."
  • "I look forward to working with Regan McGee and the outstanding team the company already has in place.
  • Phil was CTO at Cold Creek Technologies and has also held key positions at Splunk, Synopsys, Atoptech and Aristo Technologies.

Nobul Expands Leadership Team With Four New Key Executives to Accelerate Growth

Retrieved on: 
Friday, November 12, 2021

"I am very pleased to have these highly accomplished executives from Silicon Valley join Nobul's leadership team to fuel our growth.

Key Points: 
  • "I am very pleased to have these highly accomplished executives from Silicon Valley join Nobul's leadership team to fuel our growth.
  • They each have proven track records of successfully scaling businesses much smaller than Nobul to multibillion-dollar market caps and attracting stellar talent."
  • "I look forward to working with Regan McGee and the outstanding team the company already has in place.
  • Phil was CTO at Cold Creek Technologies and has also held key positions at Splunk, Synopsys, Atoptech and Aristo Technologies.

Honda Prize 2021 Awarded to French Neurosurgeon and Physicist Dr. Alim Louis Benabid

Retrieved on: 
Thursday, September 30, 2021

TOKYO, Sept. 30, 2021 /PRNewswire/ -- The Honda Foundation, the public interest incorporated foundation established by Soichiro Honda and his younger brother Benjiro and currently led by President Hiroto Ishida, is pleased to announce that the Honda Prize 2021 will be awarded to Dr. Alim Louis Benabid, Professor Emeritus of Joseph Fourier University and Chairman of the Board of Clinatec, both of France, for his contribution to pioneering research and practical application of deep brain stimulation (DBS) to the treatment of involuntary movement caused by progressive Parkinson's disease and other neurological disorders.

Key Points: 
  • DBS is a surgical procedure in which electrodes are implanted in the subthalamic nucleus in the brain.
  • The Prize will be awarded to Dr. Benabid for this innovative treatment method, which is worthy of the highest recognition.
  • This year, the presentation ceremony for the 42nd Honda Prize will be held on November 17, 2021, in an online format, to be broadcast in Japan, France and various other countries.
  • For more information about the press release and CV of Dr. Benabid, please refer to the Honda Foundation via: URL: https://www.hondafoundation.jp/news/view_en/1504